Literature DB >> 19690031

Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.

Keun Jae Ahn1, Hee Sung Hwang, Jeon Han Park, Seong Hye Bang, Won Jun Kang, Mijin Yun, Jong Doo Lee.   

Abstract

UNLABELLED: The (18)F-FDG uptake pattern on PET could be an indicator of the prognosis and aggressiveness of various tumors, including hepatocellular carcinoma (HCC). Hexokinase, especially hexokinase type II (HKII), plays a critical role in (18)F-FDG uptake in rapidly growing tumors. We established a stable cell line overexpressing HKII by the transfection of full DNA of HKII to HCC cells (SNU449) that express low levels of HKII and investigated how (18)F-FDG uptake mechanisms, especially overexpression of HKII, are linked to tumor proliferation mechanisms.
METHODS: The HKII gene was stably transfected to SNU449 cells with an expression vector. HKII expression in the cells was verified by reverse-transcriptase polymerase chain reaction, Western blot analysis, adenosine triphosphate (ATP) and lactate production, (18)F-FDG uptake measurement, and confocal microscopy. Cellular proliferation activity and response to the anticancer drug cisplatin were evaluated by cell counting using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. For the evaluation of molecular pathways involved in tumor proliferation, the phosphatidylinositol 3-kinase (PI3K)/Akt pathway was investigated.
RESULTS: The stable cell line produced HKII effectively, but expression of other enzymes or transporters for glycolysis, such as glucose-6-phosphatase (G6Pase), HKI and III, and glucose transporter type 1 and 2 (Glut-1 and Glut-2), did not show any changes. (18)F-FDG uptake was significantly increased after transfection. ATP and lactate production was also increased after transfection. Overexpressed HKII was associated with mitochondria on confocal microscopy. Cells with overexpression of HKII, compared with the nontransfected cell line, showed 1.5- to 2-fold higher cell survival and resistance to the anticancer agent cisplatin (2- to 8-fold). In the molecular study, the activated form of Akt was increased after transfection, and PI3K inhibitor dissociated the mitochondrial HKII to the cytoplasm. In addition, the adenosine monophosphate-activated protein kinase (AMPK) pathway is also involved in Akt signaling.
CONCLUSION: HKII plays an important role in (18)F-FDG uptake and tumor proliferation by both the PI3K-dependent and the PI3K-independent Akt signal pathways; therefore, the (18)F-FDG uptake pattern on a PET scan can be a surrogate marker of prognosis in HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690031     DOI: 10.2967/jnumed.108.060780

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  27 in total

1.  Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer.

Authors:  Dong Hoon Suh; Min A Kim; Haeryoung Kim; Mi-Kyung Kim; Hee Seung Kim; Hyun Hoon Chung; Yong-Beom Kim; Yong Sang Song
Journal:  Clin Exp Med       Date:  2013-08-15       Impact factor: 3.984

2.  Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.

Authors:  Byung Hyun Byun; Sung Hoon Kim; Sang Moo Lim; Ilhan Lim; Chang-Bae Kong; Won Seok Song; Wan Hyeong Cho; Dae-Geun Jeon; Soo-Yong Lee; Jae-Soo Koh; Soo Kyo Chung
Journal:  Eur Radiol       Date:  2015-02-14       Impact factor: 5.315

3.  TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in mice.

Authors:  Zhidan Luo; Liqun Ma; Zhigang Zhao; Hongbo He; Dachun Yang; Xiaoli Feng; Shuangtao Ma; Xiaoping Chen; Tianqi Zhu; Tingbing Cao; Daoyan Liu; Bernd Nilius; Yu Huang; Zhencheng Yan; Zhiming Zhu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

4.  Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma.

Authors:  Chae Hong Lim; Seung Hwan Moon; Young Seok Cho; Joon Young Choi; Kyung-Han Lee; Seung Hyup Hyun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-02       Impact factor: 9.236

5.  Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors.

Authors:  Hong Lin; Jin Zeng; Ren Xie; Mark J Schulz; Rosanna Tedesco; Junya Qu; Karl F Erhard; James F Mack; Kaushik Raha; Alan R Rendina; Lawrence M Szewczuk; Patricia M Kratz; Anthony J Jurewicz; Ted Cecconie; Stan Martens; Patrick J McDevitt; John D Martin; Stephenie B Chen; Yong Jiang; Leng Nickels; Benjamin J Schwartz; Angela Smallwood; Baoguang Zhao; Nino Campobasso; Yanqiu Qian; Jacques Briand; Cynthia M Rominger; Catherine Oleykowski; Mary Ann Hardwicke; Juan I Luengo
Journal:  ACS Med Chem Lett       Date:  2015-12-28       Impact factor: 4.345

6.  PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.

Authors:  Elena A Federzoni; Peter J M Valk; Bruce E Torbett; Torsten Haferlach; Bob Löwenberg; Martin F Fey; Mario P Tschan
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

7.  Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists.

Authors:  Shanmugasundaram Ganapathy-Kanniappan; Rani Kunjithapatham; Michael S Torbenson; Pramod P Rao; Kathryn A Carson; Manon Buijs; Mustafa Vali; Jean-François H Geschwind
Journal:  Radiology       Date:  2012-03       Impact factor: 11.105

Review 8.  Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy.

Authors:  D J Roberts; S Miyamoto
Journal:  Cell Death Differ       Date:  2014-10-17       Impact factor: 15.828

9.  Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.

Authors:  Jian Chen; Sulin Zhang; Yuncheng Li; Zhengang Tang; Weijia Kong
Journal:  Tumour Biol       Date:  2013-12-21

Review 10.  Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.

Authors:  Abudureyimu Tuerhong; Jin Xu; Si Shi; Zhen Tan; Qingcai Meng; Jie Hua; Jiang Liu; Bo Zhang; Wei Wang; Xianjun Yu; Chen Liang
Journal:  Cell Mol Life Sci       Date:  2021-06-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.